U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07329101) titled 'Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis' on Dec. 29, 2025.
Brief Summary: This is a single arm, and open-label phase I study
Study Start Date: Nov. 11, 2025
Study Type: INTERVENTIONAL
Condition:
Atopic Dermatitis (AD)
Intervention:
DRUG: VC005
VC005 with Local topical application
Recruitment Status: RECRUITING
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Published by HT Digital Content Services with permission from Health Daily Digest....